Ginkgo Bioworks DNA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.31 | 509 | -15.12 | -81 | -6.99 | 1,120 |
| 2025Q3 | 14.58 | 560 | -13.77 | -81 | -6.67 | 1,189 |
| 2025Q2 | 11.25 | 613 | -9.57 | -60 | -4.78 | 1,231 |
| 2025Q1 | 5.70 | 647 | -13.34 | -91 | -6.81 | 1,293 |
| 2024Q4 | 9.82 | 716 | -14.21 | -108 | -7.52 | 1,377 |
| 2024Q3 | 8.15 | 798 | -6.92 | -56 | -3.63 | 1,481 |
| 2024Q2 | 13.37 | 833 | -23.86 | -217 | -13.54 | 1,625 |
| 2024Q1 | 46.40 | 987 | -15.92 | -166 | -10.22 | 1,582 |
| 2023Q4 | 67.60 | 1,097 | -18.02 | -212 | -11.47 | 1,665 |
| 2023Q3 | 72.40 | 1,253 | -21.98 | -303 | -14.03 | 2,026 |
| 2023Q2 | 74.40 | 1,504 | -11.14 | -173 | -7.36 | 2,292 |
| 2023Q1 | 53.20 | 1,608 | -12.26 | -205 | -8.27 | 2,417 |
| 2022Q4 | 67.60 | 1,736 | -11.07 | -175 | -7.96 | 2,539 |
| 2022Q3 | 124.80 | 1,435 | -45.05 | -669 | -34.62 | 1,871 |
| 2022Q2 | 95.20 | 1,535 | -42.93 | -669 | -33.01 | 1,994 |
| 2022Q1 | 161.20 | 1,581 | -38.27 | -591 | -28.60 | 2,058 |
| 2021Q4 | 332.40 | 1,505 | -104.72 | -1,601 | -75.83 | 2,071 |
| 2021Q3 | 463.60 | 1,552 | -13.09 | -102 | -5.26 | 2,151 |
| 2021Q2 | 5 | -2135.10 | -107 | -6.18 | 1,726 | |
| 2021Q1 | 5 | -74 | 1,728 |